• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Trimb Acquires a Portfolio of Skin Care Brands in Northern Europe

Share:

November 12, 2018

Trimb Healthcare AB has entered into a definitive agreement with CCS Healthcare Nordic AB to acquire their portfolio of skin care products in Sweden, Norway and the UK. The portfolio includes several well-established and highly recognized brands, including CCS Swedish Formula, Indy Beauty[1], Oliva, Bamse[2], and exclusive rights to DAX and Antibac in the consumer sales channel in Sweden. The CCS Skincare Brands’ sales and marketing organization in Stockholm will transfer to Trimb as part of the transaction. The closing of the transaction is expected to occur in January 2019.

Magnus Nylén, CEO of Trimb said, “The CCS Skincare Brands have strong strategic fit with Trimb and will significantly strengthen our position in Sweden. We see meaningful marketing synergies within our core categories of skin care and foot care. CCS has built a strong foothold for their products and it is with great pride that we welcome these well-known brands to Trimb.”

Date: November 12, 2018

Source: Cision

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • PE-backed Anju Software buys Zephyr HealthPE-backed Anju Software buys Zephyr Health
  • Insights on the Eclinical Solutions Global Market to 2030: Increasing Externalization of Clinical Trial Studies By Large Pharmaceutical and Biopharmaceutical Companies – ResearchAndMarkets.ComInsights on the Eclinical Solutions Global Market to 2030: Increasing Externalization of Clinical Trial Studies By Large Pharmaceutical and Biopharmaceutical Companies – ResearchAndMarkets.Com
  • Hemostemix Announces the Incorporation of PreCerv Inc. and a Global Field of Use License to NCP-01Hemostemix Announces the Incorporation of PreCerv Inc. and a Global Field of Use License to NCP-01
  • Lilly Completes Acquisition of Prevail TherapeuticsLilly Completes Acquisition of Prevail Therapeutics
  • Dignity Health Management Services to Leverage Innovaccer’s FHIR-Enabled Data Activation PlatformDignity Health Management Services to Leverage Innovaccer’s FHIR-Enabled Data Activation Platform
  • Apollo Endosurgery, Inc. Announces Closing of Public Offering of Common Stock and Underwriter’s Full Exercise of Over-Allotment OptionApollo Endosurgery, Inc. Announces Closing of Public Offering of Common Stock and Underwriter’s Full Exercise of Over-Allotment Option
  • Acquisitions to create scale and digital alliances to bolster life sciences M&A outlook in 2019Acquisitions to create scale and digital alliances to bolster life sciences M&A outlook in 2019
  • Walgreens to Invest $1B in VillageMD to Open 500 to 700 Full-Service Doctor OfficesWalgreens to Invest $1B in VillageMD to Open 500 to 700 Full-Service Doctor Offices

Trending This Week

  • Pharmaceutical Lipids Market Revenue, Key Players, Dynamic, Demand and Drives, Forecast to 2031
  • Global High Potency Active Pharmaceutical Ingredient (HPAPI) Market Report 2022: A $34+ Billion Market in 2026 – Long-Term Forecast to 2031
  • Drug Discovery Services Market to 2027 – Size, Share & Industry Trends Analysis Report | Emergen Research
  • Global Nanomedicine Market, By Nanomolecule Type, By Nanoparticle Type, By Application By Disease Indication, By Region and Competition Forecast & Opportunities, 2027
  • Pharmaceutical Waste Disposal Services Market Size 2022 Analysis By Business Share, Strategies, Investment Opportunities, Revenue Expectation, Future Trends, Prominent Players, Industry Impact and Global Forecast Till 2025
  • AstraZeneca Rumored to Have Set Sights on Mereo BioPharma Buyout

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications